Mainz Biomed B.V.
NASDAQ:MYNZ
4.365 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -5.183 | -8.252 | -13.785 | -12.602 | -11.428 | -0.241 | -0.293 | -0.293 | -0.239 | -0.239 |
| Depreciation & Amortization
| 0.204 | 0.171 | 0.317 | 0.062 | 0.035 | 0.035 | 0.03 | 0.03 | 0.013 | 0.013 |
| Deferred Income Tax
| -0.018 | -0 | 0 | 0 | -6.487 | -1.737 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.819 | 2.096 | 4.142 | 5.682 | 6.43 | 1.608 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0.235 | 1.78 | -0.684 | 0.246 | -0.784 | 0.012 | 0.029 | 0.029 | 0.106 | 0.106 |
| Accounts Receivables
| 0.101 | 0.059 | -0.164 | -0.047 | 0.057 | -0.032 | -0.05 | -0.05 | 0.085 | 0.085 |
| Change In Inventory
| -0.158 | -0.121 | -0.134 | -0.038 | -670.725 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0.485 | -0.059 | 0 | 0 | 670.725 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -0.193 | 1.901 | -0.386 | 0.332 | -0.841 | 0.024 | 0.078 | 0.078 | 0.021 | 0.021 |
| Other Non Cash Items
| -0.713 | 0.005 | 1.697 | 0.155 | 2.659 | 0.12 | 0 | 0 | 0.016 | 0.016 |
| Operating Cash Flow
| -4.655 | -5.119 | -8.313 | -6.457 | -3.088 | -0.229 | -0.234 | -0.234 | -0.104 | -0.104 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.174 | -0.124 | -0.406 | -0.252 | -0.012 | -0.005 | -0.005 | -0.005 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 1.22 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.2 | -0.5 | 0 | 0 | 1.22 | 0 | 0.005 | 0.005 | 0 | 0 |
| Investing Cash Flow
| -0.374 | -0.124 | -0.406 | -0.252 | 1.208 | -0.005 | -0.005 | -0.005 | 0 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -1.969 | 4.389 | 0 | -0.046 | 0 | 0.217 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 4.5 | 0.611 | 0 | 0 | 2.606 | 0.503 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.935 | 0 | -0.148 | 24.137 | 10.394 | 0 | 0.019 | 0.019 | -0.008 | -0.008 |
| Financing Cash Flow
| 3.466 | 5.419 | -0.148 | 24.092 | 10.394 | 0.503 | -0.019 | -0.019 | -0.008 | -0.008 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -0.798 | -0.124 | 0.002 | -0.103 | 0.019 | -0.007 | 0.218 | 0.218 | 0 | 0 |
| Net Change In Cash
| -2.249 | 0.053 | -26.007 | 26.007 | 1.987 | 0.244 | -0.041 | -0.041 | -0.006 | -0.006 |
| Cash At End Of Period
| 7.071 | 10.911 | 0 | 26.007 | 2.182 | 0.274 | 0.061 | 0.061 | 0.051 | 0.051 |